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Based on topographical, morphological and physiological
characteristics, the three portions of the collecting duct system
are the cortical collecting tubule (CCT), the outer medullary
collecting duct (OMCD) and the inner medullary collecting duct
(IMCD). The IMCD is a direct continuation of the OMCD and
extends from the junction between the outer and inner medulla
to the tip of the papilla. Also, due to the morphological
differences observed along the IMCD, Madsen and Tisher 11]
recently have proposed a subdivision of the IMCD into three
portions as the outer third (IMCD1), middle third (IMCD2) and
inner third (IMCD3), despite there being no abrupt divisions
between the three segments. The cells of IMCD1 are similar to
the intercalated cells and principal cells of the OMCD. In the rat
the intercalated cells constitute approximately 10% of the cells
in the IMCD1. However, in most of the IMCD2 and the entire
IMCD3 there is only one cell type which appears to be different
from both principal and intercalated cells of the OMCD [1].
The functional differences between IMCDI and the terminal
two segment portions of IMCD were initially demonstrated by
Sands and Knepper [21. They showed that IMCD2 and IMCD3
exhibit similar permeabilities to urea, whereas significant dif-
ferences were demonstrated between IMCD1 and the terminal
IMCD (IMCD2 and IMCD3). Differences related to the trans-
epithelial potential have been also described between these
segments. Stanton [3] has recently demonstrated the presence
of small lumen-negative PD (—2.2 0.3 mY) in the initial part
of IMCD obtained from Brattleboro rats. Previous results from
our laboratory [4] which did not take into account the three
portions of IMCD, showed that the PD was not significantly
different from zero (0.7 0.2 mV) throughout the length of the
IMCD. These observations led us to compare the transepithelial
PD observed in the IMCD with the middle (IMCD2) and distal
parts (IMCD3) of Wistar rats. Our results confirmed the pres-
ence of a slightly lumen-negative PD in the initial segments
which differed significantly from the slightly lumen-positive
voltage observed in the middle third and distal portion of IMCD
(Fig. 1). Sands, Nonoguchi and Knepper [5] showed under
basal conditions that the ratio between apparent Na and C1
permeabilities (Na, 1) was significantly higher in the initial
IMCD than in the terminal IMCD. Thus, the IMCD can be
subdivided into two distinct subsegments, the initial IMCD or
IMCD1 and the terminal IMCD (IMCD2÷3).
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The morphological and physiological observations demon-
strate that the various mechanisms and factors that govern the
remarkable reabsorptive capacity for Na and C1 observed in
the IMCD by free flow micropuncture [61 and in vivo micro-
catheterization [7] should be analyzed in each IMCD segment
by in vitro microperfusion or cell suspension.
Mechanism of Na and C1 transport
The in vitro perfusion of isolated IMCD segments from rat
kidney allowed us to measure the unidirectional isotopic flux of
both Na and C1 which are in agreement with chemical
determinations of net Cl— flux [8]. We were able to detect under
baseline conditions a significant net absorption of Na and C1
in the presence of a small lumen-positive PD and in the absence
of both a chemical gradient and net water absorption in the
IMCD23. The lumen-to-bath flux (JIb) of both Na and Cl
was 1.5-fold the bath-to-lumen (Jbl), as illustrated in Figure 2.
Analysis of Jib of Na and Cl
The conductive properties of both the apical and basolateral
membranes of the initial portion of IMCD obtained from
Brattleboro rats [3] support a model of Na transport in which
electrogenic Na absorption is driven by Na-K-ATPase in
the basolateral membrane, with passive movement of Na
occurring through an amiloride-sensitive pathway in the apical
membrane.
We observed in the IMCD23 that amiloride iO M added to
the luminal fluid reversibly decreases the JIb of Na (Fig. 3),
with a simultaneous increase of the transtubular PD from +0.2
0.01 to +0.60 0.1 mV. Similarly, Stanton [3] observed an
increase in the lumen voltage of IMCD from —3.0 0.5 mV to
+1.4 0.9 mV when amiloride was in the bath. The presence
of a primary active W pump in the IMCD suggested by several
studies [9, 10] and described by Selvaggio et al [11] raises the
possibility that the lumen-positive potential is generated by this
proton pump. The inhibitory action of amiloride present in the
perfusing solution suggests that Na absorption in the
IMCD2÷3, similar to what is observed in the IMCD1, is partially
dependent on Na channels [3]. However, we cannot exclude
the possibility of a direct inhibition of Na-K-ATPase activity by
amiloride [12].
The important role of Na-K-ATPase in Na absorption in the
IMCD2±3 was demonstrated with in vitro microperfused tu-
bules where ouabain at iO M added to the peritubular fluid
reduced the JIb reversibly without changing the transtubular PD
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Fig. 1. Transepithelial potential difference (PD) obtained in the initial
(IMCD1), middle (IMCD2) and distal (IMCD3) parts of IMCD,
0.01.
Jib Jbl Jnet Jib Jbt Jnet
Fig. 2. Unidirectional isotopic flux of Na and Cl in the terminal
IMCD measured in basal conditions. Each column represents the mean
SEM. Symbols are: (liii) lumen-to-bath flux (Jib); () bath-to-lumen
flux (Jbl); and () net flux. The perfusion rates were 25 2 nI/mm.
(Fig. 4). These experiments suggest that 1.92 0.20 nmol/
cm2 sec of Na transport are direct or indirectly coupled to
Na-K-ATPase. Also, these experiments with ouabain provide
physiological evidence for Na-K-ATPase in the basolateral
membrane and confirm the immunocytochemical studies of
Kashgarian et al [13].
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Fig. 3. Effect of amiloride (10 M) added to the luminal fluid on Na
lumen-to-bath flux (JIb) in the terminal IMCD. Each tubule was studied
at high perfusion rates (20 to 25 nI/mm). Each point represents the mean
of three collections of one period. Lines connect data points of
individual tubules. * statistically significant (P < 0.05).
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The inhibition of NaCl absorption by ouabain without a
change in the transtubular PD suggests an electroneutral pro-
cess possibly mediated by parallel conductive pathways or
neutral cotransport or parallel ion exchange. Although our data
do not permit us to explain the mechanism of JIb in the
IMCD23, the question posed by these observations should
lead to further investigations on the mechanism of Na trans-
port.
Another point that needs to be discussed is related to the
magnitude of net sodium absorption observed in the in vitro
IMCD2÷3. Under basal conditions the IMCD2+3 of rat exhibits
a significant net Na absorption (Fig. 2). It is important to point
out that these values are similar to the ones observed by Reif,
Troutman and Schafer [14] in DOCA stimulated CCT (0.9
nmol/cm2 . see). However, the Na-K-ATPase activity deter-
mined recently by Terada and Knepper [15] in the IMCD is
lower than in the CCT. With perfect efficiency the Na-K-
ATPase level in the IMCD would predict a Na flux of 1.06
nmol/cm2 sec assuming that 3 Na ions are translocated per
molecule of hydrolyzed ATP [16]. Our data presented in Figure
4 show that ouabain reduced 35% of Na JIb, which suggests
that 1.92 0.20 nmol/cm2 sec of Na are direct or indirectly
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Fig. 4. Effect of ouabain (lO- or io- M) added to the bath fluid on
Na lumen-to-bath flux (Jib) in the terminal IMCD. Each tubule was
studied at high perfusion rates (20 to 25 nI/mm). Each point represents
the mean of three collections of one period. Lines connect data points
of individual tubules. * statistically significant (P < 0.05).
coupled to Na-K-ATPase. This discrepancy observed between
Na-K-ATPase-dependent Na transport and Na-K-ATPase
level could be explained by either: 1) absorption through the
paracellular pathway down the lumen-positive transepithelial
PD; or 2) differences between the Na-K-ATPase activity in
vitro and in vivo due to stimulating factors present in the cells
of IMCD.
The Jib of Ci is 1.5-fold the Jbl of Ci, indicating significant
net Cl absorption under basal conditions (Fig. 2). This was
substantiated by direct determination of net Cl absorption
using both isotopic and chemical measurements [8]. The mag-
nitude of Jib of C1 is approximately 90% of Na JIb, which
agrees with the hypothesis that the major part of Na absorp-
tion in the terminal IMCD is followed by C1. The inhibitory
effect of ouabain on Na Jlb without changing the transtubular
PD is suggestive evidence that Cl is cotransported with Nat
However, the mechanisms underlying this Ci outfiux in
IMCD2±3 remain unclear.
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Fig. 5. Results from six experiments showing the action of Dibutyryl
cyclic AMP (DcAMP, IO' M) and furosemide (FURO, JO si) added
to the bath fluid on Cl bath-to-lumen flux (Jbl, upper panel) and
transepithelial PD (lower panel) in rat terminal IMCD. Each tubule was
studied throughout five consecutive periods: control (CON); in pres-
ence of Dibutyryl cAMP; when furosemide was added to DcAMP in the
bath; when furosemide was withdrawn and DcAMP remained in the
bath, and finally in recovery period (REC), when DcAMP was also
withdrawn. Each point represents the mean SEM. Perfusion rates
were 20 to 25 nI/mm.
Analysis of Jbl of Na and C1
The apparent passive permeabilities for Na (PNa) and C1
(P1-) calculated from the isotopic ibi under baseline conditions
were 0.92 0.21 x iO and 1.20 0.25 x 10 cm/sec,
respectively [4]. These observations are similar to the values
obtained by Sands, Nonoguchi and Knepper [5] using the NaCl
gradient. These low permeabilities are in agreement with the
concept that, at least under certain circumstances, the IMCD
epithelium must be quite impermeable to Na and Cl so as to
maintain the final urinary concentrations as low as 1 mM/liter.
An important new feature of Jbl of Na and Cl- is our recent
observations [17] that the addition of Dibutyryl-cAMP
(DcAMP, l0— M) to the bath fluid generated a lumen-negative
transepithelial voltage in the middle and distal thirds of IMCD
perfused in vitro but not in the initial part of IMCD (Fig. 5). The
lumen-positive PD observed under basal conditions (+0.25
0.02 mV) became lumen-negative (—1.2 0.1 mV) in the
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Fig. 6. Effect ofDibutyryl cyclic AMP (DcAMP, IO M) added to the
bath fluid on the lumen-to-bath flux (Jib) and bath-to-lumen flux (fbi) o,f
Na, Cl and K in the terminal IMCD. Each column represents the
mean of six tubules. The perfusion rates were 20 to 25 nI/mm.
Ion flux Bath fluid Control DcAMP
Cl Jbl Ringer/HCO3 2.85 0.19 4.60 0.40
C1 Jbl without Na 1.76 0.17 1.71 0.15
Cl Jbl without K 1.60 0.12 1.67 0.13
Na Jbl Ringer/HCO3 2.26 0.28 4.03 0.59aNa Jbl without C1 2.14 0.22 2.16 0.23
Na Jbl without K 1.80 0.13 1.82 0.15
presence of DcAMP which returned to +0.28 0.02 mV when
DcAMP was withdrawn from the bath fluid. The isotopic fluxes
determinations showed that the lumen-negative PD generated
by DcAMP was followed by an increase in the Jbl of Nat, K
and Cl without change in Jlb (Fig. 6) of Na, Cl and K.
DcAMP stimulates Cl transport in a wide variety of trans-
porting cells. C1 secretion is stimulated in intestine, shark
rectal gland, cornea, and trachea. C1 absorption is stimulated
by cAMP in the thick ascending limb of Henle's loop [181.
Electrophysiological investigations with conventional intracel-
lular microelectrodes indicate that cAMP decreases the frac-
tional resistance of the luminal membranes and depolarizes the
intracellular voltages, which is consistent with the induction of
a Cl conductance in the luminal membrane.
As with several other epithelia [18], the stimulated effect of
cAMP on Jbl of Cl— and the generation of lumen-negative PD in
the IMCD2±3 were blocked by furosemide (10—6 M) and bumet-
anide (a specific inhibitor of Na-K-Cl cotransport) added to the
peritubular fluid but not in the luminal side (Fig. 5).
To further evaluate the characteristics of the transport pro-
cess for the IMCD2±3 secretion of Na, Cl and K, experi-
ments were performed using the ion substitution technique [17].
The replacement of NaCI by choline in the bath fluid blocked
the DcAMP-stimulated Jbl of C1. Also, in the group of
experiments where K was selectively replaced by Na in the
bath fluid (K free solution) the DcAMP-stimulated Cl influx
was completely inhibited (Table I). These results indicate that
C1 Jbl observed in the IMCD and stimulated by DcAMP
requires all three of the above ions. The Jbl of Na stimulated
by DcAMP was also inhibited by the replacement of C1 in the
Perfusion
rates
ni/mm
JIb of Na
nmol/cm2 . sec
Perfusion
rates
nI/mm
Jbl of Na
nmol/cm2 sec
7.6 0.4 3.18 0.44 8.1 0.5 2.06 0.07
25.6 1.2 4.76 0.44a 26.2 1.5 2.52 0.20
The Jib at low and high perfusion rates are significantly different (P
<0.01).
bath fluid by isotonic Na2SO4 and by the absence of K in the
bath. Similarly, the Jbl of K was not stimulated by DcAMP in
the absence of Cl in the bath solution (Table 1).
The observed interdependence of Nat, K and C1 fluxes by
the ion substitution technique and the inhibition by bumetamide
and furosemide described above is compatible with the exist-
ence of Na-K-Cl cotransport system operating in the basolateral
membrane of IMCD23.
The effect of Na-K-ATPase inhibition was examined to
characterize the DcAMP-stimulated Jbl of C1. The addition of
0.1 mM ouabain to the solution bathing the basal surface
partially inhibited both the DcAMP-stimulated Jbl of C1 and
the lumen-negative potential (Table 2).
These data led us to accept the general scheme for Cl
secretion described for several secretory epithelia [18]. C1
entry into the cell, against its electrochemical gradient across
the basolateral membrane, coupled to K and Na entry is
driven by the chemical gradient for Na established by Na-K-
ATPase. The entry step is inhibited by furosemide. C1 exits
rheogenically across the luminal membrane along its own
electrochemical gradient. As in some other epithelia, increased
levels of cell cAMP augments luminal membrane Cl conduc-
tance or increases the number of functioning basolateral mem-
brane Na-K-Cl transport units.
Recently, Grupp et al [201, using highly purified papillary
collecting duct cells obtained from Wistar rats, studied the ion
dependence, the inhibitor sensitivity of ion transport-related
lactate production and the ion fluxes across the plasma mem-
brane by electroprobe microanalysis. The results also suggest
that the cell of IMCD contain a Na-K-Cl cotransport system
which might be involved in transepithelial chloride transport or
volume regulation of IMCD cells. Sands, Knepper and Spring
[21], found a Na-K-Cl cotransport in the apical membrane of the
rabbit papillary surface epithelium. However, more recently
Packer, Sands and Knepper [22] from the same laboratory
showed that the papillary surface epithelium has different
permeability characteristics and that it is not a functional
extension of the terminal IMCD.
The stimulation of Nat, Cl and K secretion by cAMP in
the IMCD implies that the rates of NaCI secretion are under
hormonal control and that this secretion may contribute mea-
surably to the final urine sodium chloride excretion. Therefore,
the IMCD participates in the hormonal regulation of urinary
NaCI excretion by two mechanisms: Na-K-ATPase-dependent
NaC1 absorption and NaCl secretion generated by Na-K-Cl
cotransport system.
Atrial natriuretic factor (ANF)
Effects of ANF on water transport in the IMCD have been
demonstrated by Nonoguchi, Sands and Knepper [23] and by
Chloride Sodium
cAMP Con cAMP
Potassium
Con cAMP6
2
0
Table 2. Effect of altering flow rate on both lumen-to-bath flux (Jlb)
and bath-to-lumen flux (Jbl) of Na in the terminal IMCD
Table 1. Effect of ion substitution on Dibutyryl cAMP-stimulated
bath-to-lumen flux (Jbl, nmol/cm2 . sec) of CI and Na in the
terminal IMCD
P < 0.01
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our laboratory 1241. Indeed, in vivo microcatheterization stud-
ies of the IMCD suggest that ANF directly or indirectly inhibits
fractional sodium reabsorption [251. In addition to the possibil-
ity of a direct effect of ANF on IMCD, Zeidel et a! [261 have
shown, in fresh suspensions of rabbit IMCD, that ANF inhibits
epithelial Na channels as defined by amiloride-sensitive inhi-
bition of 22Na uptake. Investigations have demonstrated the
existence of specific receptors for ANF in the glomerulus and in
the papillary segment of the medulla [27]. Moreover, ANF
stimulates the accumulation of cGMP in a number of tissues,
and it has been suggested that this cyclic nucleotide is the
intracellular mediator of ANF [28]. Cultured papillary collect-
ing ducts also respond to ANF with increased accumulation of
cGMP [29]. Specific ANF binding sites and cGMP accumula-
tion of the IMCD suggest a direct effect of ANF on this tubular
segment.
Using the in vitro microperfusion of IMCD2±3 obtained from
Wistar rat, we were able to demonstrate that ANF present in
the bath fluid reverts the sodium net flux from absorption to
secretion, which is reversible when the hormone was with-
drawn [8]. This observation was confirmed simultaneously by
chemical and by isotopic determination of net chloride absorp-
tion [8].
The presence of Na secretion in the IMCD has been
suggested as a possible contributing factor to natriuresis pro-
duced by volume expansion in studies with in vivo microcath-
eterization [30]. However, Sands, Nonoguchi and Knepper [5],
measuring the effect of ANF on Na and Pci of IMCD obtained
from Sprague-Dawley rats treated previously with furosemide,
did not show any change in Na
The net secretion of Na and decrease in net Cl absorption
observed in the presence of ANF were due to a decrease in the
JIb of Na and Jlb of C1 associated with an important increase
of Jbl of Na and Jbl of Cl— (Figs. 7,8). ANF increased Cl— Jbl,
generated a negative lumen electrical potential and also stimu-
lated Jbl of Na1 and Jbl of K, as in the effect described above
with DcAMP. The effect of ANF on Jbl of Cl- and PD is
completely reversed by low concentrations of furosemide (10—6
M) added to ANF in the bath fluid (Fig. 8). These data suggest
the presence of an ANF-stimulated Na-K-Cl cotransport sys-
tem in the IMCD2÷3 of Wistar rat. In agreement with this
hypothesis are the experiments which show that the absence of
Na or C1 blocked the ANF-stimulated Jbl of C1 or Nat,
respectively [8].
Therefore, the IMCD participates in the ANF regulation of
NaCI excretion by two mechanisms: one which inhibits Na
entry into the IMCD cell and another one which stimulates Na
and C1 secretion by the Na-K-Cl cotransport system. This
conclusion is in accordance with recent studies from Nushiro et
a! [31] in which amiloride pretreatment did not affect the
natriuretic effect induced by ANF, suggesting that there is
another mechanism by which ANF induces natriuretic action,
in addition to the effects mediated by interference with the
sodium conductive channels. The observation of NaCI secre-
tion in the isolated IMCD is similar to that found in the shark
rectal gland, vascular smooth muscle and endothelial cells,
where ANF stimulates NaCI secretion by increasing the Na-
K-Cl cotransport system [32—34].
The experiments with cGMP clearly demonstrated that
cGMP could mediate the effect of ANF on JIb and Jbl of both
CON AVP AVP
+
ANF
Na and Cl— in the rat IMCD [8]. As with ANF, cGMP (10 M
or 106 M) added to the bath fluid reduced the Na Jib which
was reversed when cGMP was withdrawn from the bath fluid.
In addition, we observed that the Jbl of both Na and Cl
increased reversibly when cGMP was added to the bath fluid,
and generated a lumen-negative PD similar to that observed in
the presence of ANF (Fig. 9).
Radioligand binding studies reveal that the dissociation con-
stant of the ANF receptor was in the range of 10_b M to iO
M. Recently developed radioimmunoassay methods have
shown that the plasma concentration of ANF falls within this
range [35]. Finally, the threshold concentration for increased
cGMP accumulation by ANF has been shown to range from 0.1
to 1 flM, which is in the range reported for rat plasma [36]. We
observed that the minimum concentration of ANF (10_Il M)
capable of stimulating Cl secretion and generating a lumen-
negative PD is within the physiological range [8].
Vasopressin
Vasopressin (VP) increases the transport of Na and the H20
permeability in anuran membranes and CCT [37—39]. We have
observed that lysine vasopressin (LVP) and arginine vasopres-
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Fig. 7. Inhibitory effect of ANF (6 nM) on arginine vasopressin (A VP,
50 pJJ/ml)-siimulated Na lumen-to-bath flux (Jib) in rat terminal
IMCD at a high perfusion rates (20 to 25 nI/mm). Each point represents
the mean SEM of six experiments of one period. Each IMCD was
studied throughout the three consecutive periods. p < 0.01.
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Fig. 8. Results from experiments showing the action of ANF (6 nM)
and furosemide (FURO, 106 M) added to the bath fluid on both
chloride and sodium bath-to-lumen fluxes (Jib) upper panel and trans-
epithelial PD (lower panel) of rat terminal JMCD. Each point repre-
sents the mean SEM of one period. Each LMCD was studied during the
four consecutive periods. Perfusion rates were 20 to 25 nI/mm. *D <
0.01.
sin (AVP) produce an increase in net absorption of Na
followed by an increase in the transtubular PD in the in vitro
perfused IMCD2÷3 [401; LVP caused a rapid and sustained
increase in Na Jib without affecting Jbl in IMCD2÷3 (Figs. 7,
10) similar to what has been described in the rat CCT [14]. The
observation that Jbl remains unaffected by LVP is in agreement
with the absence of a significant effect of AVP on 24Na
permeability, observed recently by Sands et al in rat IMCD [5].
Most investigators have concluded that AVP increases 1Na
in the mucosal cell surface of toad bladder and frog skin,
increasing the Na concentration within the cell and thus
increasing the quantity of Na available for the active transport
step at the basolaterai membrane [41]. Another alternative is
that VP directiy increases active transport in the basolateral
membrane step. Our observation of an inhibitory effect of
ANJF amiloride added to the luminal fluid on VP-stimulated Na
lumen-to-bath flux [40] led us to conclude that VP action on
Na influx is dependent on the presence of amiloride-sensitive
Na channels similar to those observed in toad bladder [41] and
CCT [37]. Furthermore, Figure 11 shows that ouabain com-
pletely inhibited the VP-dependent increase of Na4 Jib, sug-
gesting that the effect of LVP on Na-K-ATPase activity could
be a direct one, or an indirect one, secondary to an increase in
the activity of apical membrane Na channels [41, 42].
Our observations [40] that DcAMP does not stimulate the
Na Jib (Fig. 10) suggest that the stimulatory action of AVP on
Na absorption in the IMCD is mediated by the Vi pathway
[43]. In agreement with this hypothesis are the observations
shown in the Figure 10 that dDAVP, a specific V2-agonist
coupled to the cAMP cascade, was not able to increase the Na
Jib. Accordingly, Sonnemberg, Honrath and Wilson [44]
showed that dDAVP stimulates K secretion in the IMCD but
Na reabsorption remained unchanged. In this point, the effect
of dDAVP in the IMCD differs from the thick ascending limb
where the activation of V2 receptors by dDAVP increases the
net absorption of NaCI [19]. This conclusion was confirmed by
the inhibitory effect of a selective Vi-antagonist d (CH2) Tyr
(Me) AVP [45] on LVP-stimulated Na Jlb (Fig. 12). Likewise,
Star et al [46] have shown that exogenous cAMP mimicked the
effect of vasopressin on both urea and water permeability but
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Fig. 9. Effect of cGMP (I0 M) on the unidirectional lumen-to-bath
flux of Na (JIbN,,+) and bath-to-lumen flux of Na and C1 (JblNc,
Jblcr) in the terminal IMCD. Each point represents the mean SEM of
one period. Each IMCD was studied during three consecutive periods.
Perfusion rates were 20 to 25 nI/mm. < 0.05.
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did not produce a measurable change in intracellular Ca2
concentration. We have found that the absence of Ca2 com-
pletely inhibits VP-stimulated Na Jib [40]. The presence of
Ca2 appears to have a physiological significance in VP regu-
lation of Na influx in the IMCD.
The important question is why there is an increase in the
lumen-positive PD by VP addition to the bath fluid and the PD
remains unchanged when the Na Jib is reduced by ouabain.
The presence of a primary active H pump in the IMCD
described by Selvaggio et ai [11] raises the possibility that the
lumen-positive potential is generated by this proton pump
which could be stimulated directly or indirectly by VP. The
absorption stimulated by VP without generating lumen-negative
voltage is in agreement with the presence of neutral NaCI
transport or counter-balancing electrogenic processes stimu-
lated by VP in the luminal membrane of IMCD2±3.
Prostagiandin (PGE2)
Several observations suggest the participation of renal pros-
tagiandins in the regulation of fluid and electrolyte excretion
CON OUA OUA
[47, 481. Studies conducted in vivo have demonstrated an
increase in Na excretion following POE2 infusion, and an
inhibition of endogenous renal prostaglandin synthesis with
indomethacin has resulted an antinatriuresis. The natriuretic
action of PGE2 results from its vasodilatory properties and/or
from a direct effect on membrane sodium transport.
Prostaglandins are formed by different renal cell types: med-
ullary interstitial cells, endothelial cells of arteries and arteri-
oles, glomerular epithelial and mesangial cells and both cortical
and medullary collecting tubule cells. However, the principal
and most potent natriuretic prostaglandin is PGE2, which is
synthesized predominantly in the papillary interstitial cells and
the epithelial cells of the IMCD; this raises the possibility that
endogenous POE2 may regulate Na and water transport in the
vicinity of the site of their production [49].
lino and Imai [50], and Stokes and Kokko [51] have shown
that PGE2 decreases PD and Na absorption in the CCT as well
as the OMCD. In contrast to these observations, Fine and
Trizna [52] have shown in the OMCD and CCT that PGE2,
PGF2, and thromboxane A2 do not change the PD and sodium
absorption. These discrepant results appear to be due to differ-
ences in experimental conditions. Few studies have been de-
signed to address the possible role of POE2 on altering Na
transport in the IMCD.
Recently we have analyzed directly the effect of exogenous
PGE2 and indomethacin (an inhibitor of the synthesis of pros-
taglandin) on Na transport across the in vitro perfused
IMCD2+3 isolated from Wistar rat kidneys [53]. Figure 13
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Fig. 11. The effect of lysine vasopressin (LVP, 10 /.LU/ml) on the Na
lumen-to-bath flux (Jib) in the terminal IMCD in the presence of
ouabain (OUA, 10 M or i0 M). Each tubules was studied during four
consecutive periods: control (CON), after addition of ouabain to the
bath, when LVP was added to ouabain, and finally when these
substances were withdrawn from the bath fluid (REC). *JC < 0.01.
CON EXP REC
Fig. 10. Effect of arginine vasopressin (A VP, 50 U/ml), Dibutyryl
cyclic AMP (DcAMP, 1O M) and dDAVP (50 ixU/mi) on the Na
lumen-to-bath flux (Jib) and the effect of AVP (50 p.U/ml) on Na
bath-to-lumen (fbi) in the terminal IMCD. Each point represents the
mean SEM of one period. Each IMCD was studied during three
consecutive periods: control (CON), experimental period (EXP) and
recovery (REC). Perfusion rates were 20 to 25 nI/mm. < 0.01.
Rocha and Kudo: Na and C/transport across the IMCD 661
Fig. 12. Effect of vasopressin-antagonist (d (CH2) Tyr (Me) AVP) on
lysine-vasopressin (L VP, 10 UIml)-stimulated Na Iumentobath flux
in the terminal IMCD. Each tubule was studied during four consecutive
periods: control (CON); in presence of LVP; when antagonist VI
(VI-ant) was added to the LVP in the bath fluid; and when the VI-ant
was withdrawn from the bath and LVP remained. Each point represents
the mean SEM of one period. Perfusion rates were 20 to 25 nI/mm. *P
<0.01.
summarizes the results of these experiments in which each
tubule serve as its own control. These results provided the first
piece of evidence that PGE2 can affect Na transport of IMCD
directly. PGE2 in doses of l0 M to 106 M, when applied to
the peritubular surface, causes a decrease in the Jib of Na
without a significant change in the Jbl of Na. The Jib of Na
can be inhibited by as much as 50% by l0 M PGE2, without
significant change in the transepithelial PD, contrary to what
was observed in the CCT [50, 51]. The evidence that this action
of PGE2 is physiologically significant is supported by the
determination of papillary PGE2 showing levels in the renal
medulla which fall well within the effective dose range utilized
in our experiments [49], Since PGE2 did not show any effect on
the luminal side [53], PGE2 might act directly on the peritubular
membrane at the locus of their production.
The mechanism whereby PGE2 inhibits Na transport across
the IMCD remains to be established. The demonstration that
the back-flux of sodium was unaffected suggests that PGE2 may
directly or indirectly inhibit active Na transport.
The role of PGE2 in the regulation of Na transport in the
IMCD was substantiated by the opposite effect observed in the
experiments where indomethacin, which decreases biosynthe-
sis of prostanoids, added to the bath fluid in the absence of
CON PGE2 REC
Fig. 13. Effect of prostaglandin (PGE2) added to the bath fluid on the
lumen-to-bath flux (, Jib) and bath-to-lumen flux (0, fbi) of Na in
the terminal IMCD. Each tubule was studied during three consecutive
periods: control (CON), in presence of PGE2, and when PGE2 was
withdrawn from the bath (REC). Each point represents the mean SEM
of one period. Perfusion rates were 20 to 25 nI/mm. *P < 0.01.
vasopressin increased the Na Jlb reversible (Fig. 14). These
data are in support of the hypothesis that endogenous PGE2
suppresses Na transport in IMCD [53, 541. Similarly to that
described above for vasopressin action, the stimulating effect of
indomethacin on Na JIb was blocked by the presence of
amiloride l0 Mon the luminal side of IMCD23 (Fig. 14). This
observation indicates that the PGE2 action on Na outfiux
depends on a pre-existing population of amiloride-sensitive
Na channels. These data suggest that PGE2 may modulate
Na transport in vivo and may contribute to the final regulation
of sodium excretion.
Epidermal growth factor
Epidermal Growth Factor (EGF), a potent mitogen in a
variety of cell lines in vitro and in vivo [55, 56], is a 6,000
molecular wt peptide first isolated by Carpenter and Cohen
from mouse submaxillary gland [55]. The circulating blood
levels of EGF are normally approximately 50 M [56] and higher
levels are found in the urine. It has been suggested that high
levels of EGF have a trophic function for the urinary epithe-
hum. Primary cultures of several nephron segments are stimu-
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Fig. 14. Effect of indomethacin (10 M) added to the bath fluid in
absence and in presence of luminal amiloride (AMIL, 10 M) on Na
lumen-to-bath flux (Jib) in the terminal IMCD. Each tubule was studied
during three consecutive periods: control (CON), in presence of indo-
methacin and when indomethacin was withdrawn from the bath fluid.
Each point represents the mean SEM of one period. Perfusion rates
were 20 to 25 nI/mm. *D < 0.01.
lated by EGF. Specific affinity receptors for EGF have been
found in several segments of rabbit nephron such as the
proximal convoluted tubules, pars recta, thick ascending limb
and CCT. Recently Harris [57] showed that rat renal papillary
collecting duct cells possess specific receptors with a high
affinity for EGF.
On the other hand, recent studies have demonstrated that
intracellular sodium regulates several cellular processes in
epithelial cells, including cellular growth [58]. However, the
relationship between Na transport in each nephron segment
and cellular growth produced by the EGF is poorly understood.
In vivo studies have demonstrated that EGF administered
systematically or directly in the renal artery increases urine
flow and Na excretion. Studies using in vitro microperfusion
of isolated segments of rabbit CCT showed that EGF inhibits
the hydrosmotic effect of AVP [59] and the Na JIb without
changing the Na Jbl [60]. The mechanism by which EGF
Fig. 15. Effect of epidermal growth factor (EGF, 10-8 M) added to the
bath fluid on the lumen-to-bath flux (& JIb) and bath-to-lumen flux (0,
fbi) of Na in the terminal IMCD. Each tubule was analyzed during
three consecutive periods: control (CON), in presence of EGF and
when the hormone was withdrawn from the bath. Each point represents
the mean SEM of one period. Perfusion rates were 20 to 25 nI/mm. *D
<0.01.
modifies VP-stimulated water transport and Na absorption in
the CCT has not been established yet. However, more recently,
Harris [57], studying the EGF of rat IMCD cells in cultures and
in fresh suspensions, observed an increase in 3H-thymidine
incorporation and an increase in both 3H-arachidonic acid
release and POE2 synthesis. These observations raise the
possibility that the inhibitory effect of EGF on Na and H20
transport in the IMCD could be mediated by an increase in the
PGE2 which inhibits the VP-stimulated water transport and
Na absorption. In the CCT the mechanism of EGF action may
be different since its effects on the water flow response to AVP
were not affected by indomethacin pretreatment [59].
The presence of high-affinity EGF receptors in the IMCD
cells indicates that the IMCD may serve as an important target
for EGF [57]. Preliminary studies from our laboratory [61] have
demonstrated that EGF (108 M) added to the peritubular side
of rat IMCD2÷3 perfused in vitro reduces the Na JIb without
changing the Jbl (Fig. 15). The inhibitory effect was obtained in
20 minutes and the removal of EGF resulted in complete
recovery of Na JIb after 15 to 30 minutes. The minimum
effective concentration of EGF in the bath fluid solution on Na
Jlb (10 M) comparing with plasma and urinary levels of EGF
suggest that physiological concentrations of EGF are able to
inhibit JIb of Nat. These observations are in agreement with
the recent studies of Vehaskari et at [60] which analyzed the
effect of EGF in the rabbit CCT.
The observation by Harris [57] that POE2 induced significant
arachidonate release and increased PGE2 production in cul-
tured IMCD cells led us to analyze the hypothesis that POE2 is
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Fig. 16. Effect of indomethacin (INDO, iO M) on the inhibitory effect
of epidermal growth factor (EGF, 10" M) on lumen-to-bath flux ofNa in the terminal IMCD. Each tubule was analyzed during five
consecutive periods: control (CON), in presence of EGF in the bath,
when indomethacin was added to the EGF in the bath fluid, when the
indomethacin was withdrawn and the EGF remained, and finally when
the EGF was withdrawn (REC). Each point represents the mean SEM
of one period. Perfusion rates were 20 to 25 nI/mm. *D < 0.01.
the mediator of EGF function on electrolyte transport in the
IMCD. Figure 16 shows that JIb of Na inhibited by the EGF
addition (iO— M) is blocked when indomethacin (l0— M), an
inhibitor of POE2 synthesis, was added to the bath. The values
of Na Jib returned to the previous values when the inhibitor of
POE2 synthesis was withdrawn from the bath fluid and the EGF
remained, which indicated that the inhibitory effect of indo-
methacin was completely reversible. Finally, the removal of
EGF from the bath was also followed by an increase in JIb of
Nat These experiments are in agreement with the possibility
that the inhibitory effect of EGF on Na transport in the IMCD
is mediated by an increase in PGE2 production [611.
In summary, the experiments described above indicate that
EGF may be an important factor in the regulation of Na and
water transport in the IMCD2+3.
Diuretics: Furosemide, amiloride and thiazide
It has been proven that the diuretics such as amiioride and
furosemide are useful not only to the clinician concerned with
proper drug therapy but also to the cell physiologist concerned
with molecular probes for the understanding of Na and Cl
transport across membranes. Moreover, several studies in vivo
have suggested that the IMCD is a potentially important site of
action of these diuretics [62, 631.
Furosemide
In addition to its well-known effect on NaC1 reabsorption in
the ioop of Henle, furosemide has been implicated by Sonnem-
berg in the complete inhibition of Na and water absorption in
IMCD of the rat kidney. Whether this is a direct action of
furosemide on IMCD or an indirect consequence of inhibition of
asceding limb transport needs to be clarified. Early studies from
our iaboratory [64] using the in vitro microperfusion technique
showed that furosemide (10 M) added to the peritubular side
in the absence of AVP did not change the Na Jib, nor was Na
Jbl changed in the absence of DcAMP. However, furosemide at
l0 or 106 M was able to inhibit the AVP-stimuiated Jib of
Na in the IMCD2±3 without changing Jbl of Nat The time to
achieve the maximal effect of furosemide in the bath on
VP-stimulated Na transport was 10 to 20 minutes and the
effect was entirely reversible. These observations are illustrated
in Figure 17. This effect is comparable to the recently described
effect of furosemide on VP-stimulated water and urea transport
in the IMCD [65].
Proximal tubule secretion of furosemide results in an elevated
concentration in tubule fluid, which then flows into the lumen of
the thick ascending limb of Henle's loop where it acts. How-
ever, contrary to this observation, furosemide (10 M) does
not have an effect on IMCD when present in the luminal fluid
REC [65].
The agreement between Sonnemberg [62] and Wilson et al's
[66] observations with our results can be explained when one
considers the fact that in vivo microcatheterization was per-
formed in anesthetized rats where plasma VP levels were
probably elevated.
Several studies have demonstrated that furosemide inhibits
NaCl transport in the thick ascending limb of Henle and in other
tissues [67—69] by inhibition of Na-K-Cl cotransport systems
present in the luminal or the peritubular membranes. However,
the absence of furosemide effect on Jib of Na when added to
the luminal fluid rules against the possibility of a similar
mechanism in the luminal membrane of IMCD. On the other
hand, the inhibitory effect of furosemide on Jib of Na only in
the presence of VP led us to relate the inhibitory mechanism of
furosemide action to the pathways of vasopressin-stimulated
activity on JIb of Na in the IMCD.
The studies presented above suggest that the VP-stimulated
Jib of Na is mediated by Vi receptors and a consequent
increase in the amiloride-sensitive conductive pathway in the
apical membrane of IMCD. Thus, the inhibitory effect of
furosemide on VP-stimulated Na outfiux should be on the Vi
receptor pathway or on the luminal sodium conductivity. Fur-
ther studies are required to address this somewhat unusual
possibility.
Amiloride
Amiloride administered in dogs, rats and humans results in
modest increases in the urinary excretion of Nat, bicarbonate
and chloride while causing a striking reduction of urinary K
excretion [70]. Amiloride is secreted by the proximal tubule and
reaches high concentrations in the luminal side [71]. Several
investigations have shown that this diuretic acts at proximal
tubule, CCT and OMCD. Figure 3 presents the effect of iO M
amiloride added to luminai fluid of rat IMCD2+3 perfused in
vitro. This drug reduces the Na Jib to values close to the Na
Jbl. Stanton [3] corroborated this inhibitory effect in initial
IMCD using identical amiloride concentrations. Ziedel et al
[26], in agreement, showed that this diuretic at iO M de-
creases the oxygen consumption of rabbit IMCD cell suspen-
sions.
There are at least two kinds of Na transport mechanisms
which are sensitive to amiloride: a conductive Na entry
pathway responsive to i0 M concentrations and a Na-H
electroneutral exchange system which requires much higher
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Fig. 17. Effect offurosemide (FURO, 10-6 M)
added to the bath fluid in absence and in
presence of arginine vasopressin (A VP, 50
p.UIml) on the lumen-to-bath flux (A, Jib) and
bath-to-lumen flux (0, fbI) of Na in the
terminal JMCD. The left side illustrates the
effect of FURO in absence of AVP studied
during two consecutive periods: control
(CON) and when FURO was added to the
bath. The left side illustrates the experiments
where the Na Jib in the terminal IMCD was
analyzed during five consecutive periods:
control (CON); in presence of AVP; when
FURO was added to AVP in the bath fluid;
when FURO was withdrawn from the bath
and AVP remained; and when AVP was also
withdrawn from the bath, recovery (REC)
period. Each point represents the mean
SEM of one period. Perfusion rates were 20 to
25 nI/mm. *D < 0.01.
Fig. 18. Effect of hydrochlorothiazide (l0- M) added to the bath fluid
on the lumen-to-bath flux (A, JIb) and bath-to-lumen flux (0, fbI) ofNa in the terminal IMCD. Each tubule was studied during three
consecutive periods: control (CON); in presence of thiazide and recov-
ery period; and when the diuretic was withdrawn from the bath. Each
point represents the mean SEM of one period. Perfusion rates were 20
to 25 nI/mm. < 0.01.
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concentrations of amiloride to be inhibited. The experiments
described above indicate the presence of high conductance
channels in the three portions of IMCD, but the effect of high
concentrations of amiloride (10 M) or selected amiloride
derivatives on the luminal and basolateral cell membrane of
IMCD remain to analyzed to determine the presence of
Na-H exchange systems.
Thiazides
Clearances, micropuncture and microperfusion studies have
demonstrated clearly that the major important site of thiazide
action is the distal convoluted tubule [72, 73]. The inhibition by
thiazides of Na absorption in the proximal tubule is consid-
ered relatively unimportant for natriuresis [74, 75]. However,
recently Wilson et al observed that thiazide diuretics decrease
chloride, sodium and fluid absorption in the IMCD catheterized
in vivo [631. He showed that, in spite of the increased fluid and
electrolyte delivery, the fraction of delivered fluid Na and Cl
absorbed in the IMCD was reduced markedly by hydrochlo-
rothiazide. The observed effect on NaCI absorption of IMCD
could be due to a direct action on IMCD cells or an indirect one
generated by the decrease of medullary tissue solute concen-
trations, thus decreasing the gradient for NaCI and H20 absorp-
tion. Recently, we have extended these studies using the in
vitro microperfusion technique and we were able to demon-
strate that hydrochlorothiazide (lO— M) added to the luminal
fluid decreases the Na Jib reversibly without changing the
Na Jbl. However, hydrochlorothiazide added to the bath did
not change the Jbl of Na nor the JIb of Na. These results are
illustrated in Figure 18.
The neutral sodium-dependent chloride transport mechanism
may be present in the luminal membrane of IMCD23 due to the
observed inhibitory effect of ouabain on JIb of Na without
changes in the transepithelial PD. This transport may involve
Nat-Cl cotransport, Na-K-Cl cotransport, or parallel antiport
of Na/H and C1/HC03. We observed in the IMCD that
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furosemide added to luminal fluid did not change Na-Cl
transport, which excluded the possible existence of Na-K-Cl
cotransport system in the luminal membrane of IMCD2±3 [65].
Recent observations from Shimizu et a! [73], in agreement with
several investigators, have demonstrated that thiazides inhibit
an electroneutral transport of NaCl in the rabbit distal nephron,
which is similar to our findings in IMCD2±3. The presence of a
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Fig. 19. Schematic representation of the factors governing Na and
C1 transport in rat IMCD2 and !MCD3. The Na and C1 transport
mechanisms remain to be completely clarified.
parallel antiport of Na/H and C11HC03 in the IMCD3
cannot be ruled out.
In summary, the effects of furosemide, amiloride and thiazide
addition to the luminal fluid of rat IMCD suggests that Na and
C1 transport in the luminal membrane includes at least two
differents means of transport: Na-Cl cotransport and an
amiloride-sensitive conductive Na pathway.
Mineralocorticoids
The isolated perfused CCT from rats which did not receive
deoxycorticosterone (DOC) have transepithelial PD's close to
zero and exhibit little Na transport. However, chronic admin-
istration of DOC causes an important increase in the Na Jib
and generates a significant lumen-negative PD in CCT [75]. The
increase in Na transport in CCD produced by DOC is directly
or indirectly associated to an increase in Na-K-ATPase activity
by an average of 200% [15].
The PD in the in vitro isolated perfused IMCD2÷3 obtained
from rat and rabbit kidneys was unchanged by chronic DOC
administration [4]. Micropuncture studies by Uhlich et al [76,
77] show that aldosterone increases the net Na flux of IMCD
despite the decrease in 24Na efflux; the conclusion is that
aidosterone decreases Recently, Sands et al [5] have
confirmed the lower Na in DOC treated rats. These results
suggest that an increase of net Na absorption in the IMCD23
is consequent to a decrease in the passive back-flow of Na.
However, Terada and Knepper [15] demonstrated that the
administration of DOC increased the levels of Na-K-ATPase
activity in all subsegments of IMCD. It is unclear whether the
functional and biochemical changes described are a direct effect
of DOC on IMCD cells or associated with changes in Na
delivery to the IMCD, or are an escape from the Nat-retaining
effect of DOC. Therefore, the effect of aldosterone on Na and
Cl transport in the IMCD requires further investigation.
Flow and load dependence of NaCI absorption
Increasing flow rates have been found to increase the elec-
trolyte transport in the proximal tubule, loop of Henle and distal
tubule [78, 79]. Load and flow dependence of Na reabsorption
in the IMCD have been observed in micropuncture studies [61
and in vivo microcatheterization [621. More recently, Cupples
and Sonnemberg [80] showed that the reabsorption of Na and
C1 to be strongly load-dependent. We have observed that an
increase in the flow rates from 7.0 to 25 nI/mm during the in
vitro perfusion of rat IMCD2÷3 determined an increase in the
Na Jib without significant changes in Na Jbl (Table 2).
Variations in the transepithelial PD were not observed. These in
vivo and in vitro observations suggest: 1) the amount of Na
absorbed by IMCD compared with its excretion points out the
importance of this nephron segment in the regulation of Na
excretion; 2) the IMCD normally does not operate close to its
maximum absorptive capacity and an increase in delivery
should lead to a similar increase in Na absorption; 3) the
variation in Na absorption determined by flow rate and Na
delivery associated with the stimulatory effect of hormonal
factors provides the IMCD with more capacity to regulate Na
excretion. However, the mechanism by which the flow rate and
Na load increase the absorption of Na remains to be clari-
fied.
The factors governing Na and C1 transport in the terminal
IMCD presented in this paper are summarized in Figure 19,
which displays the target of each factor. Two types of cells are
proposed because we thought that this was the most acceptable
hypothesis to explain the NaCI secretion and absorption in the
terminal IMCD.
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